BRUNO, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 14.388
EU - Europa 1.905
AS - Asia 1.722
SA - Sud America 234
AF - Africa 31
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 2
Totale 18.288
Nazione #
US - Stati Uniti d'America 14.331
SG - Singapore 811
DE - Germania 608
CN - Cina 409
RU - Federazione Russa 271
IT - Italia 222
UA - Ucraina 201
BR - Brasile 192
IE - Irlanda 155
VN - Vietnam 145
HK - Hong Kong 129
GB - Regno Unito 128
FR - Francia 79
SE - Svezia 78
FI - Finlandia 60
JP - Giappone 50
KR - Corea 45
CA - Canada 38
NL - Olanda 30
BD - Bangladesh 23
IN - India 22
ZA - Sudafrica 20
AR - Argentina 19
BE - Belgio 15
PL - Polonia 14
UZ - Uzbekistan 13
MX - Messico 12
TR - Turchia 12
ID - Indonesia 11
AT - Austria 9
CZ - Repubblica Ceca 9
PH - Filippine 8
IQ - Iraq 7
SA - Arabia Saudita 7
PY - Paraguay 6
CO - Colombia 5
CH - Svizzera 4
DK - Danimarca 4
EC - Ecuador 4
ES - Italia 4
PK - Pakistan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
DZ - Algeria 3
EU - Europa 3
IR - Iran 3
KG - Kirghizistan 3
NP - Nepal 3
AE - Emirati Arabi Uniti 2
CL - Cile 2
DO - Repubblica Dominicana 2
EG - Egitto 2
GE - Georgia 2
IL - Israele 2
LT - Lituania 2
MY - Malesia 2
PE - Perù 2
RO - Romania 2
TW - Taiwan 2
VE - Venezuela 2
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CG - Congo 1
CR - Costa Rica 1
DM - Dominica 1
GA - Gabon 1
GD - Grenada 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
JO - Giordania 1
KE - Kenya 1
LB - Libano 1
MA - Marocco 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
TH - Thailandia 1
UY - Uruguay 1
Totale 18.288
Città #
Woodbridge 4.157
Wilmington 3.250
Houston 2.876
Singapore 506
Ann Arbor 450
Chandler 443
Fairfield 354
Ashburn 274
San Jose 208
Dallas 189
Jacksonville 179
Beijing 168
Dublin 153
Hong Kong 128
New York 123
Seattle 119
The Dalles 117
Dearborn 115
Cambridge 110
Medford 109
Santa Clara 81
Rome 73
Los Angeles 65
Ho Chi Minh City 59
Zhengzhou 53
Lawrence 50
Munich 49
Tokyo 44
Council Bluffs 37
Lauterbourg 34
Buffalo 31
Hanoi 29
Moscow 28
São Paulo 24
Montreal 19
San Diego 19
London 18
Chicago 17
Orem 17
Brooklyn 16
Brussels 15
Hefei 15
Johannesburg 15
Mülheim 14
Milan 13
Wuhan 13
Amsterdam 12
Helsinki 12
Nanjing 12
Columbus 11
Norwalk 11
Palo Alto 11
University Park 11
Warsaw 11
Boardman 10
Boston 10
Frankfurt am Main 10
Shanghai 10
Chennai 9
Menlo Park 9
North Bergen 9
San Francisco 9
Brno 8
Denver 8
Manchester 8
Atlanta 7
Colorado Springs 7
Creede 7
Mexico City 7
Mountain View 7
Nuremberg 7
Rio de Janeiro 7
Stockholm 7
Ankara 6
Biên Hòa 6
Center 6
Guangzhou 6
Kunming 6
Nürnberg 6
Redondo Beach 6
Turku 6
Burago di Molgora 5
Da Nang 5
Paris 5
Redwood City 5
Riyadh 5
Seoul 5
Toronto 5
Verona 5
Belo Horizonte 4
Detroit 4
Falls Church 4
Hebei 4
Hounslow 4
Inverigo 4
Jakarta 4
Mumbai 4
Nanchang 4
Phoenix 4
Pittsburgh 4
Totale 15.255
Nome #
A microgranular variant of acute promyelocytic leukemia with atypical morpho-cytochemical features and an early myeloid immunophenotype 532
CD7 expression in acute myeloid leukemia 529
AML-M0: A review of laboratory features and proposal of new diagnostic criteria 513
Collection of peripheral progenitor cells: a comparison between Amicus and Cobe-Spectra blood cell separators 509
Minimally differentiated acute myeloid leukemia (AML-MO): a distinct clinico-biologic entity with poor prognosis 498
Analysis of the expression of adhesion molecules on CD34+ progenitors from bone marrow, umbilical cord blood and G-CSF mobilized peripheral blood 497
All-trans-retinoic acid plus low-doses of cytarabine for the treatment of poor-risk acute myeloid leukemias 495
Biological profile of 23 cases of minimally differentiated acute myeloid leukemia (AML-MO) and its clinical implications 471
Leukocyte alkaline-phosphatase score in plasma-cell dyscrasias - correlation with disease severity and circulating levels of granulocyte-colony-stimulating factor 470
Multiparametric analysis for the enumeration of CD34+ cells from bone marrow and stimulated peripheral blood 470
Diagnosis of acute myeloid leukemia and system Coulter VCS 469
P-glycoprotein and terminal transferase expression identify prognostic subsets within cytogenetic risk classes in acute myeloid leukemia 463
Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia 462
Minimally differentiated acute myeloid leukemia (AML-MO): Comparison of 25 cases with other French-American-British subtypes 461
Prognostic relevance of the expression of Tdt and CD7 in 335 cases of acute myeloid leukemia 461
Biological features of acute myeloid leukemia in the elderly 460
P-glycoprotein and BCL-2 levels predict outcome in adult acute lymphoblastic leukaemia 448
AML-M0: a biological and clinical profile 445
Biological pattern of AML-M0 versus AML-M1: Response 441
Contribution of immunophenotypic and genotypic analysis to the diagnosis of acute leukemia 432
Minimally differentiated acute myeloid-leukemia (aml-mo): cytochemical, immunophenotypic and cytogenetic analysis of 19 cases 432
Clinical significance of soluble p53 protein in B-cell chronic lymphocytic leukemia 431
Evaluation of biological features of cord blood units collected with different methods after cesarean section 428
Red blood cell depletion and cryopreservation of umbilical cord blood (UCB) 423
All-trans retinoic acid and low dose cytosine arabinoside for the treatment of "poor prognosis" acute myeloid leukemia 422
Minimally differentiated acute myeloid leukemia (AML-MO): A distinct clinico-biologic entity with poor prognosis 416
P-glycoprotein expression in de novo acute myeloid leukemia 416
Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia. 412
Lineage identification of acute leukemias: relevance of immunological and ultrastruttural techniques 399
Triple immunofluorescence evaluation of CD15, CD34 and Class-II expression by flow-cytometry in normal and leukemic bone marrows 399
Deregulation of the mitochondrial apoptotic machinery and development of molecular targeted drugs in acute myeloid leukemia 370
Apoptosis and immaturity in acute myeloid leukemia 362
Spontaneous apoptosis and proliferation detected by BCL-2 and CD71 proteins are important progression indicators within ZAP-70 negative chronic lymphocytic leukemia. 357
CD69 is independently prognostic in chronic lymphocytic leukemia: acomprehensive clinical and biological profiling study 356
Analysis of the expression of adhesion molecules on CD34+ progenitors from bone marrow, umbilical cord and G-CSF stimulated peripheral blood 352
Prognostic value of cell marker analysis in de-novo acute myeloid-leukemia 350
The addition of rituximab to fludarabine improves clinical outcome in untreated patients with ZAP-70-negative chronic lymphocytic leukemia 345
Prototypical proinflammatory cytokine (IL-1) in multiple sclerosis: role in pathogenesis and therapeutic targeting 194
Exercise protects from hippocampal inflammation and neurodegeneration in experimental autoimmune encephalomyelitis 169
Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis 167
Emerging Role of Extracellular Vesicles in the Pathophysiology of Multiple Sclerosis 155
Re-Examining the Role of TNF in MS Pathogenesis and Therapy 146
Fatal acute graft-versus-host disease in Sézary Syndrome treated with Mogamulizumab and hematopoietic cell transplantation 141
Impaired nodal shrinkage and apoptosis define the independent adverse outcome of NOTCH1 mutated patients under ibrutinib therapy in chronic lymphocytic leukaemia 140
Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis 138
MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis 128
The BDNF Val66Met Polymorphism (rs6265) Modulates Inflammation and Neurodegeneration in the Early Phases of Multiple Sclerosis 124
Corrigendum: Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis 115
COVID-19 vaccines in multiple sclerosis treated with cladribine or ocrelizumab 96
The microRNA let-7b-5p Is Negatively Associated with Inflammation and Disease Severity in Multiple Sclerosis 89
Interleukin 6 SNP rs1818879 Regulates Radiological and Inflammatory Activity in Multiple Sclerosis 79
Osteopontin Is Associated with Multiple Sclerosis Relapses 77
Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosis 75
Fatigue in Multiple Sclerosis Is Associated with Reduced Expression of Interleukin-10 and Worse Prospective Disease Activity 73
Theoretical and therapeutic implications of the spasticity-plus syndrome model in multiple sclerosis 71
Single-dose pegylated-filgrastim versus daily filgrastim after high-dose chemotherapy and autologous stem cell transplantation for lymphoid malignancies: delayed platelets recovery? 49
Totale 18.422
Categoria #
all - tutte 44.806
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.806


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202119 0 0 0 0 0 0 0 0 0 0 0 19
2021/2022579 15 57 5 48 10 85 24 24 50 59 31 171
2022/2023947 91 84 85 114 68 212 81 47 92 15 39 19
2023/2024312 44 7 12 2 31 117 10 1 2 3 24 59
2024/20251.280 42 345 175 55 32 52 73 68 115 128 113 82
2025/20262.401 249 110 398 199 181 124 334 250 256 204 89 7
Totale 18.422